Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy.
Kuksa, L; Andrejak, C; Haecker, B; Bothamley, G; Calcagno, A; Cirillo, DM; Duarte, R; Fatima, R; Ferlazzo, G; Guglielmetti, L; Günther, G; Hewison, C; Horsburgh, CR; Jäger, T; Kalancha, Y; Otto-Knapp, R; KRANZER, K; Lillebaek, T; Marks, G; Middelkoop, K; Motta, I; Rabinova, V; Sommerfeld, P; Tattevin, P; Lange, C;
2025
IJTLD open, (2025).2 3 10.5588/ijtldopen.25.0152.
Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials.
Jerene, D; Van Kalmthout, K; Levy, J; Alacapa, J; Deyanova, N; Dube, T; Mganga, A; Tasca, B; Bogdanov, A; Efo, E; Gamazina, K; Garfin, AM C; Kochanov, V; Leung, A; Madden, N; Maraba, N; MCQUAID, CF; Mleoh, L; Onjare, B; Powers, R; Terleiva, Y; Van Rest, J; Gebhard, A; FIELDING, K; Charalambous, S;
2025
Lancet (London, England), (2025).405 10485 10.1016/S0140-6736(24)02847-2.
Efficacy of BCG vaccination on incidence, severity and clinical progression of COVID-19: A BCG-REVAC population analysis.
De Souza, RA; Barreto, FR; De Jesus Lima, CC O; Da Natividade, MS; De Souza Teles Santos, CA; Ichihara, MY; Pereira, M; De Castro, DB; Genser, B; RODRIGUES, LC; Barreto, ML; Pereira, SM;
2025
Vaccine, (2025).54, 10.1016/j.vaccine.2025.126911.
Host-directed therapy in diabetes and tuberculosis comorbidity toward global tuberculosis elimination.
Smith, SG; Bowness, R; CLIFF, JM;
2025
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (2025).155, 10.1016/j.ijid.2025.107877.
Scaling-up symptom-agnostic, community-wide screening toward global tuberculosis elimination: opportunities, challenges, and lessons from history.
Esmail, H; Miller, C; Falzon, D; De Vries, G; Chijioke-Akaniro, O; HORTON, KC; Kohli, M; Dharmapuri Vachaspathi, T; Vo, LN Q; Zaidi, SM A; Squire, SB; Coussens, AK; HOUBEN, RM G J;
2025
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (2025).155, 10.1016/j.ijid.2025.107875.
Process Evaluation of Pragmatic Cluster-Randomized Trials of Digital Adherence Technologies for Tuberculosis Treatment Support: A Mixed-Method Study in Five Countries.
Madden, N; TADESSE, AW; Leung, CL; Gonçalves Tasca, B; Alacapa, J; Deyanova, N; Ndlovu, N; Mokone, N; Onjare, B; Mganga, A; Van Kalmthout, K; Jerene, D; FIELDING, K;
2025
Tropical medicine and infectious disease, (2025).10 3 10.3390/tropicalmed10030068.
Tissue-specific T cell profiles in Mycobacterium tuberculosis uninfected IGRA negative and positive individuals.
Ahimbisibwe, G; Nakibuule, M; SSEJJOBA, MM; Bisoboka, CP; Akello, FG; Turyasingura, MJ; Mulwana, R; Nabulime, J; Babirye, F; Kizito, MA; Lekuya, HM; Adakun, AS; Nalumansi, D; Muryasingura, S; Lukande, R; Baluku, JB; Biraro, IA; COSE, S;
2025
Frontiers in Tuberculosis, (2025).3, 10.3389/ftubr.2025.1535945.
Disseminated Tuberculosis Driving Secondary Haemophagocytic Lymphohistiocytosis Following Adalimumab and Treatment for Latent Tuberculosis.
Seers, T; Quah, H; Ludwig, D; Noursadeghi, M; Brown, M; MOORE, DA; Manson, JJ;
2025
British journal of hospital medicine (London, England : 2005), (2025).86 3 10.12968/hmed.2024.0462.
Bacille Calmette-Guérin-specific IgG titres among infants born to mothers with active tuberculosis disease in Uganda.
SITENDA, D; Ssekamatte, P; Nakavuma, R; Kyazze, AP; Bongomin, F; Baluku, JB; Nabatanzi, R; Kibirige, D; Wilkinson, RJ; Nakimuli, A; COSE, S; Andia-Biraro, I;
2025
BMC immunology, (2025).26 1 10.1186/s12865-025-00692-w.
ERASE-TB: prediction models for Mtb infection dataset.
CALDERWOOD, C; Marambire, E; KRANZER, K;
2025
, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2025). 10.17037/DATA.00004571.